Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02122809 | Phase I Study of Chiauranib in Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | Chipscreen Biosciences, Ltd.INDUSTRY | 1 | Jun 17, 2016 | clinicaltrials |
| NCT02805166 | PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy | completed | Phase 4 | 420 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 17, 2016 | clinicaltrials |
| NCT02076230 | A Phase 1 TH-302 Mass Balance Trial | completed | Phase 1 | 10 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Jun 10, 2016 | clinicaltrials |
| NCT00036946 | VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | — | Regeneron PharmaceuticalsINDUSTRY | 1 | Jun 3, 2016 | clinicaltrials |
| NCT00045266 | VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | — | Regeneron PharmaceuticalsINDUSTRY | 1 | Jun 3, 2016 | clinicaltrials |
| NCT01912222 | Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction | completed | Phase 1 | 48 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 2, 2016 | clinicaltrials |
| NCT00933777 | SORAVE - Sorafenib and Everolimus in Solid Tumors(SORAVE) | completed | Phase 1 | 36 | University of CologneOTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT01349296 | BIBF 1120 and RAD001 in Solid Tumors - Phase I(BARIS) | completed | Phase 1 | 18 | University of CologneOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT00658658 | Panitumumab in Children With Solid Tumors | completed | Phase 1 | 31 | AmgenINDUSTRY | 1 | May 18, 2016 | clinicaltrials |
| NCT01418677 | An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function | completed | Phase 1 | 19 | Eisai Inc.INDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT02215850 | Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours | completed | Phase 1 | 24 | Welichem Biotech Inc.INDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT01327313 | A Study of EMD525797 in Solid Tumor Patients in Japan | completed | Phase 1 | 27 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | May 13, 2016 | clinicaltrials |
| NCT01353781 | Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies | completed | Phase 1 | 39 | AstraZenecaINDUSTRY | 1 | Apr 26, 2016 | clinicaltrials |
| NCT00896662 | Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 | completed | — | 9 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 25, 2016 | clinicaltrials |
| NCT01391533 | Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors(SARMET) | completed | Phase 1 | 72 | SanofiINDUSTRY | 4 | Apr 13, 2016 | clinicaltrials |
| NCT01711034 | A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer | completed | Phase 1 | 145 | Otsuka Pharmaceutical Development & Commercialization, Inc.INDUSTRY | 1 | Apr 5, 2016 | clinicaltrials |
| NCT00816335 | Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors | completed | Early Phase 1 | 65 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2016 | clinicaltrials |
| NCT01357330 | Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 18 | SanofiINDUSTRY | 1 | Apr 1, 2016 | clinicaltrials |
| NCT01276496 | Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery | completed | Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 15, 2016 | clinicaltrials |
| NCT01461538 | Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies | completed | Phase 2 | 84 | Seagen Inc.INDUSTRY | 1 | Mar 4, 2016 | clinicaltrials |
| NCT01683149 | Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies | completed | Phase 1 | 13 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 4, 2016 | clinicaltrials |
| NCT00303732 | Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors(PTK/RAD) | completed | Phase 1 | 37 | Daniel George, MDOTHER | 1 | Mar 3, 2016 | clinicaltrials |
| NCT01664000 | A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Cellceutix CorporationINDUSTRY | 1 | Feb 24, 2016 | clinicaltrials |
| NCT01450384 | Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 37 | Virginia Commonwealth UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT00554268 | Trial of PBI-05204 in Advanced Cancer Patients | completed | Phase 1 | 58 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 19, 2016 | clinicaltrials |
| NCT01798654 | EUS-FNA for Patients With Antithrombotic Agents | completed | — | 84 | Hokkaido Pancreatobiliary Endoscopic Intervention Study GroupNETWORK | 1 | Feb 19, 2016 | clinicaltrials |
| NCT01844661 | Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. | completed | Phase 1 / Phase 2 | 20 | Hospital Infantil Universitario Niño Jesús, Madrid, SpainOTHER | 1 | Feb 19, 2016 | clinicaltrials |
| NCT00714181 | Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 38 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT00282009 | Internet and Telephone Counseling for Smoking Cessation | completed | N/A | 2,205 | Georgetown UniversityOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT01300533 | A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 58 | BIND TherapeuticsINDUSTRY | 1 | Feb 9, 2016 | clinicaltrials |
| NCT02444884 | MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors | completed | Phase 1 | 54 | Children's Oncology GroupNETWORK | 0 | Feb 9, 2016 | clinicaltrials |
| NCT00732836 | Hepatic Arterial Infusion (HAI) of Abraxane | completed | Phase 1 | 64 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 5, 2016 | clinicaltrials |
| NCT00920868 | XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib(XAD) | completed | Phase 1 | 22 | Herbert Hurwitz, MDOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT01209091 | Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden | completed | — | 200 | GlaxoSmithKlineINDUSTRY | 0 | Feb 3, 2016 | clinicaltrials |
| NCT01061749 | Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2016 | clinicaltrials |
| NCT00008125 | Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | University of PittsburghOTHER | 1 | Jan 15, 2016 | clinicaltrials |
| NCT00888134 | Selumetinib in Cancers With BRAF Mutations | completed | Phase 2 | 28 | National Cancer Institute (NCI)NIH | 1 | Jan 15, 2016 | clinicaltrials |
| NCT01748721 | MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 27 | MorphotekINDUSTRY | 1 | Jan 8, 2016 | clinicaltrials |
| NCT02533895 | Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood | completed | Phase 1 | 67 | Activartis BiotechINDUSTRY | 1 | Dec 29, 2015 | clinicaltrials |
| NCT00110357 | Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors | completed | Phase 1 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00014378 | Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT00082290 | Massage Therapy in Treating Patients With Cancer Pain | completed | Phase 2 | 92 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT01056029 | Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | GenSpera, Inc.INDUSTRY | 1 | Dec 10, 2015 | clinicaltrials |
| NCT00053846 | Buspirone in Reducing Shortness of Breath in Patients With Cancer | completed | Phase 2 / Phase 3 | 432 | University of RochesterOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT00471445 | Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients | completed | Phase 3 | 462 | Gary MorrowOTHER | 1 | Nov 9, 2015 | clinicaltrials |
| NCT00602420 | Prevention of Pegfilgrastim-Induced Bone Pain (PIBP) | completed | Phase 3 | 510 | Gary MorrowOTHER | 1 | Nov 9, 2015 | clinicaltrials |
| NCT02056392 | To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers | completed | Phase 1 | 54 | AstraZenecaINDUSTRY | 1 | Nov 9, 2015 | clinicaltrials |
| NCT00547547 | High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 22 | City of Hope Medical CenterOTHER | 1 | Nov 6, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Jun 17, 2016source: clinicaltrials